Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Integrating genetic and blood cell data improves chronic lymphocytic leukemia (CLL) risk prediction. Combining germline genetic variation, polygenic risk scores (PGS), and clonal hematopoiesis (CH) enhances identification of individuals at high risk for CLL.
Area Of Science
- Hematology
- Genetics
- Cancer Epidemiology
Background
- Chronic lymphocytic leukemia (CLL) risk is influenced by both inherited genetic variations and acquired mutations.
- Current risk prediction models for CLL can be improved by integrating diverse risk factors.
Purpose Of The Study
- To assess if incorporating a CLL-associated polygenic score (PGS) and markers of clonal hematopoiesis (CH), specifically autosomal mosaic chromosomal alterations (mCAs) and CH of indeterminate potential (CHIP), can enhance CLL risk stratification.
- To evaluate the discriminative ability of integrative models combining germline, somatic, and clinical data for CLL risk prediction.
Main Methods
- Analysis of 436,784 participants from the UK Biobank and 35,382 from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
- Investigated associations between specific autosomal mCAs, CHIP mutations in lymphoid driver genes, and CLL risk.
- Developed integrative models incorporating sex, age, smoking status, blood cell traits, genetic similarity, CLL PGS, autosomal mCAs, and CHIP.
Main Results
- Individual mCAs and CHIP mutations were significantly associated with CLL risk.
- Integrative models incorporating CLL PGS and CH demonstrated the highest discriminative ability for CLL risk stratification.
- The predictive utility of CH waned approximately five years after measurement.
- Sensitivity analyses confirmed persistent increased discriminative ability even after excluding individuals with abnormal blood cell counts or CH.
Conclusions
- Integrating germline genetic data (PGS) with somatic data (CH) significantly improves the ability to identify individuals at high risk for CLL.
- The combined assessment of genetic predisposition and clonal hematopoiesis offers enhanced stratification for CLL risk.
- Peripheral blood data, encompassing germline and somatic information, is crucial for advanced CLL risk identification.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Commitment is the process whereby stem cells:
lose their ability to form all cell types and
irreversibly change into a specific type.
The multipotent hematopoietic stem cells, (HSCs), differentiate into the multipotent hematopoietic progenitor cells, (HPCs). The HPCs express many lineage-specific cytokine receptors. Each of these receptors binds specific cytokines, activates distinct signaling pathways, and expresses a particular gene set. The HPCs further differentiate to...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...